Masimo Corp (MASI)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$157.47
Buy
$158.09
$4.06 (+2.64%)
Masimo Corp is a medical technology company. The company develops, manufactures, and markets noninvasive monitoring technologies. Its product includes noninvasive blood constituent and brain and breath monitoring.
Prices updated at 09 May 2025, 15:53 BST
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
| Year | Gross margin (%) | Operating margin (%) | Net margin (%) | EBITDA margin (%) | EBITDA |
|---|---|---|---|---|---|
| 2024 | 47.96 | 1.80 | -14.56 | -7.58 | -159m |
| 2023 | 49.00 | 8.02 | 3.98 | 11.56 | 237m |
| 2022 | 52.01 | 10.32 | 7.05 | 17.45 | 355m |
| 2021 | 65.24 | 22.26 | 18.53 | 25.04 | 310m |
| 2020 | 64.96 | 22.32 | 21.01 | 25.64 | 293m |
| 2019 | 67.09 | 23.59 | 20.92 | 27.51 | 258m |
| 2018 | 66.98 | 24.29 | 22.55 | 27.45 | 236m |
| 2017 | 66.06 | 23.26 | 15.79 | 26.14 | 207m |
| 2016 | 67.10 | 23.28 | 43.64 | 25.64 | 183m |
Valuation data table
| Year | Price / Sales | Price earnings | Price / Cash flow |
|---|---|---|---|
| 2025 | 3.87 | - | 45.26 |
| 2024 | 4.40 | 114.00 | 40.32 |
| 2023 | 3.00 | 71.91 | 610.28 |
| 2022 | 4.75 | 48.83 | 62.11 |
| 2021 | 14.01 | 72.83 | 73.02 |
| 2020 | 14.16 | 69.71 | 71.60 |
| 2019 | 9.85 | 47.32 | 41.92 |
| 2018 | 7.11 | 41.62 | 26.88 |
| 2017 | 6.23 | 13.29 | 13.94 |
| 2016 | 5.25 | 32.56 | 24.36 |
| 2015 | 3.57 | 27.86 | 27.16 |
Price/Forward earnings (YTD)
-
Returns
Debt profile
Returns data table
| Year | Return on assets (%) | Return on equity (%) | Return on invested capital (%) |
|---|---|---|---|
| 2024 | -10.76 | -25.23 | -12.58 |
| 2023 | 2.61 | 6.03 | 5.33 |
| 2022 | 5.63 | 9.93 | 8.16 |
| 2021 | 12.76 | 15.52 | 15.15 |
| 2020 | 15.46 | 18.66 | 17.91 |
| 2019 | 15.38 | 18.36 | 17.10 |
| 2018 | 18.79 | 22.86 | 22.06 |
| 2017 | 14.46 | 19.43 | 19.19 |
| 2016 | 43.75 | 74.46 | 74.44 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 2.50 |
| 2023 | 2.23 |
| 2022 | 2.40 |
| 2021 | 1.22 |
| 2020 | 1.22 |
| 2019 | 1.20 |
| 2018 | 1.19 |
| 2017 | 1.25 |
| 2016 | 1.46 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
